Sleep Number Earnings Calls
| Release date | Nov 05, 2025 |
| EPS estimate | $0.150 |
| EPS actual | $0.0700 |
| EPS Surprise | -53.33% |
| Revenue estimate | 332.418M |
| Revenue actual | 342.879M |
| Revenue Surprise | 3.15% |
| Release date | Jul 30, 2025 |
| EPS estimate | -$0.120 |
| EPS actual | -$1.09 |
| EPS Surprise | -808.33% |
| Revenue estimate | 364.084M |
| Revenue actual | 327.925M |
| Revenue Surprise | -9.93% |
| Release date | Apr 30, 2025 |
| EPS estimate | -$0.110 |
| EPS actual | -$0.380 |
| EPS Surprise | -245.45% |
| Revenue estimate | 397.946M |
| Revenue actual | 393.261M |
| Revenue Surprise | -1.18% |
| Release date | Mar 05, 2025 |
| EPS estimate | -$0.220 |
| EPS actual | -$0.180 |
| EPS Surprise | 18.18% |
| Revenue estimate | 461.111M |
| Revenue actual | 376.817M |
| Revenue Surprise | -18.28% |
Last 4 Quarters for Sleep Number
Below you can see how SNBR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 05, 2025 |
| Price on release | $12.89 |
| EPS estimate | -$0.220 |
| EPS actual | -$0.180 |
| EPS surprise | 18.18% |
| Date | Price |
|---|---|
| Feb 27, 2025 | $14.52 |
| Feb 28, 2025 | $14.07 |
| Mar 03, 2025 | $12.69 |
| Mar 04, 2025 | $12.63 |
| Mar 05, 2025 | $12.89 |
| Mar 06, 2025 | $7.49 |
| Mar 07, 2025 | $7.57 |
| Mar 10, 2025 | $7.40 |
| Mar 11, 2025 | $7.01 |
| 4 days before | -11.23% |
| 4 days after | -45.62% |
| On release day | -41.89% |
| Change in period | -51.72% |
| Release date | Apr 30, 2025 |
| Price on release | $7.79 |
| EPS estimate | -$0.110 |
| EPS actual | -$0.380 |
| EPS surprise | -245.45% |
| Date | Price |
|---|---|
| Apr 24, 2025 | $6.57 |
| Apr 25, 2025 | $7.01 |
| Apr 28, 2025 | $7.40 |
| Apr 29, 2025 | $7.59 |
| Apr 30, 2025 | $7.79 |
| May 01, 2025 | $8.05 |
| May 02, 2025 | $7.13 |
| May 05, 2025 | $7.07 |
| May 06, 2025 | $6.99 |
| 4 days before | 18.57% |
| 4 days after | -10.27% |
| On release day | 3.34% |
| Change in period | 6.39% |
| Release date | Jul 30, 2025 |
| Price on release | $7.01 |
| EPS estimate | -$0.120 |
| EPS actual | -$1.09 |
| EPS surprise | -808.33% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $8.40 |
| Jul 25, 2025 | $8.28 |
| Jul 28, 2025 | $9.00 |
| Jul 29, 2025 | $8.16 |
| Jul 30, 2025 | $7.01 |
| Jul 31, 2025 | $7.33 |
| Aug 01, 2025 | $7.14 |
| Aug 04, 2025 | $7.60 |
| Aug 05, 2025 | $9.10 |
| 4 days before | -16.55% |
| 4 days after | 29.81% |
| On release day | 4.56% |
| Change in period | 8.33% |
| Release date | Nov 05, 2025 |
| Price on release | $5.29 |
| EPS estimate | $0.150 |
| EPS actual | $0.0700 |
| EPS surprise | -53.33% |
| Date | Price |
|---|---|
| Oct 30, 2025 | $5.45 |
| Oct 31, 2025 | $5.50 |
| Nov 03, 2025 | $5.11 |
| Nov 04, 2025 | $5.50 |
| Nov 05, 2025 | $5.29 |
| Nov 06, 2025 | $4.77 |
| Nov 07, 2025 | $4.61 |
| Nov 10, 2025 | $4.36 |
| Nov 11, 2025 | $4.28 |
| 4 days before | -2.94% |
| 4 days after | -19.09% |
| On release day | -9.83% |
| Change in period | -21.47% |
Sleep Number Earnings Call Transcript Summary of Q3 2025
Sleep Number reported a disappointing Q3 (net sales $343M, down 19.6% YoY) driven largely by significant media spend reductions and an aggressive competitive Labor Day environment. Management characterizes the business as undergoing a comprehensive turnaround after the CEO's first six months. Key financial actions: an amendment and extension of the bank agreement to end of 2027 (giving breathing room to invest), and aggressive cost reductions (operating expenses down ~$115M year-to-date with an expectation to exceed a $130M cost-out target). Q3 adjusted EBITDA was $13.3M (down $14.4M YoY); the company recorded $41M of restructuring and other nonrecurring charges (about $30M noncash). Updated full-year guidance: net sales ~ $1.4B, gross profit margin ~60%, operating expenses of ~$825M (down ~$135M vs. 2024), adjusted EBITDA ~ $70M, and negative free cash flow ~ $50M. Management expects to stabilize sales and return to growth in 2026 by (1) simplifying and refreshing the product assortment (targeting early 2026 launches and value-driven price moderation within the premium segment), (2) modernizing and reallocation of marketing to more efficient channels (media was down ~32% in Q2–Q3), (3) expanding distribution (tests including HSN and other selective channel partnerships), (4) optimizing and rationalizing store footprint and other fixed costs. Q4 is expected to show modest improvement (media down only slightly vs. prior year) and benefit from the 53rd week, but recovery to targeted levels is planned for 2026. Management reiterated focus on generating free cash flow to pay down debt and compliance with the new covenants under the amended credit agreement.
Sign In
Buy SNBR